Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Vaccines

  Free Subscription


Articles published in Nat Immunol

Retrieve available abstracts of 54 articles:
HTML format



Single Articles


    February 2024

  1. A mechanism for BCG vaccine cross-protection against pulmonary viral infections.
    Nat Immunol. 2024 Feb 21. doi: 10.1038/s41590-024-01775.
    PubMed    



  2. A nasal vaccine elicits protective CD8(+) T cell immunity against antigen shifted SARS-CoV-2 virus.
    Nat Immunol. 2024 Feb 20. doi: 10.1038/s41590-024-01744.
    PubMed    


  3. YING B, Darling TL, Desai P, Liang CY, et al
    Author Correction: Mucosal vaccine-induced cross-reactive CD8(+) T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
    Nat Immunol. 2024 Feb 15. doi: 10.1038/s41590-024-01781.
    PubMed    


  4. YING B, Darling TL, Desai P, Liang CY, et al
    Mucosal vaccine-induced cross-reactive CD8(+) T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
    Nat Immunol. 2024 Feb 9. doi: 10.1038/s41590-024-01743.
    PubMed     Abstract available


    January 2024

  5. Building a next-generation, two-component protein subunit vaccine against monkeypox virus.
    Nat Immunol. 2024 Jan 18. doi: 10.1038/s41590-023-01735.
    PubMed    



  6. Baseline immune characteristics linked to pneumococcal vaccine responsiveness in older adults.
    Nat Immunol. 2024 Jan 5. doi: 10.1038/s41590-023-01737.
    PubMed    


  7. RAVICHANDRAN S, Erra-Diaz F, Karakaslar OE, Marches R, et al
    Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults.
    Nat Immunol. 2024 Jan 5. doi: 10.1038/s41590-023-01717.
    PubMed     Abstract available


  8. RESCIGNO M
    BCG-mediated viral protection goes biphasic.
    Nat Immunol. 2024;25:13-14.
    PubMed    


    December 2023
  9. FORD ES, Mayer-Blackwell K, Jing L, Laing KJ, et al
    Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8(+) T cells in persons with previous COVID-19.
    Nat Immunol. 2023 Dec 6. doi: 10.1038/s41590-023-01692.
    PubMed     Abstract available


    November 2023
  10. LEE A, Floyd K, Wu S, Fang Z, et al
    BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance.
    Nat Immunol. 2023 Nov 30. doi: 10.1038/s41590-023-01700.
    PubMed     Abstract available


    October 2023
  11. MILLS KHG
    How immunology can help reverse the pertussis vaccine failure.
    Nat Immunol. 2023 Oct 2. doi: 10.1038/s41590-023-01625.
    PubMed    


    September 2023
  12. PAINTER MM, Johnston TS, Lundgreen KA, Santos JJS, et al
    Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection.
    Nat Immunol. 2023 Sep 21. doi: 10.1038/s41590-023-01613.
    PubMed     Abstract available


  13. ZHANG B, Upadhyay R, Hao Y, Samanovic MI, et al
    Multimodal single-cell datasets characterize antigen-specific CD8(+) T cells across SARS-CoV-2 vaccination and infection.
    Nat Immunol. 2023 Sep 21. doi: 10.1038/s41590-023-01608.
    PubMed     Abstract available


  14. ANTOUN E, Peng Y, Dong T
    Vaccine-induced CD8(+) T cells are key to protection from SARS-CoV-2.
    Nat Immunol. 2023 Sep 21. doi: 10.1038/s41590-023-01621.
    PubMed    


    August 2023
  15. HASSERT M, Harty JT
    Alt-RNAtive vaccines elicit anti-malarial T(RM) cells.
    Nat Immunol. 2023 Aug 14. doi: 10.1038/s41590-023-01594.
    PubMed    


    July 2023
  16. GANLEY M, Holz LE, Minnell JJ, de Menezes MN, et al
    mRNA vaccine against malaria tailored for liver-resident memory T cells.
    Nat Immunol. 2023 Jul 20. doi: 10.1038/s41590-023-01562.
    PubMed     Abstract available


    June 2023
  17. GAO GF
    Two-birds-one-stone approach to combine protein and mRNA vaccines for COVID-19.
    Nat Immunol. 2023 Jun 19. doi: 10.1038/s41590-023-01539.
    PubMed    


  18. KAPLONEK P, Cizmeci D, Kwatra G, Izu A, et al
    ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19.
    Nat Immunol. 2023 Jun 15. doi: 10.1038/s41590-023-01513.
    PubMed     Abstract available



  19. Immunity to COVID after vaccination in First Nations peoples is affected by comorbidities.
    Nat Immunol. 2023;24:901-902.
    PubMed    


  20. ZHANG W, Kedzierski L, Chua BY, Mayo M, et al
    Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities.
    Nat Immunol. 2023;24:966-978.
    PubMed     Abstract available


    May 2023
  21. SILVA-CAYETANO A, Fra-Bido S, Robert PA, Innocentin S, et al
    Spatial dysregulation of T follicular helper cells impairs vaccine responses in aging.
    Nat Immunol. 2023 May 22. doi: 10.1038/s41590-023-01519.
    PubMed     Abstract available


  22. JEYANATHAN M, Vaseghi-Shanjani M, Afkhami S, Grondin JA, et al
    Author Correction: Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut-lung axis.
    Nat Immunol. 2023 May 9. doi: 10.1038/s41590-023-01525.
    PubMed    


    April 2023
  23. VISAN I
    Primary vaccination imprint.
    Nat Immunol. 2023 Apr 24. doi: 10.1038/s41590-023-01515.
    PubMed    


  24. NUNEZ NG, Schmid J, Power L, Alberti C, et al
    High-dimensional analysis of 16 SARS-CoV-2 vaccine combinations reveals lymphocyte signatures correlating with immunogenicity.
    Nat Immunol. 2023 Apr 24. doi: 10.1038/s41590-023-01499.
    PubMed     Abstract available


    March 2023
  25. VISAN I
    Vaccine-induced memory.
    Nat Immunol. 2023 Mar 23. doi: 10.1038/s41590-023-01489.
    PubMed    


    January 2023

  26. Lipid homeostasis mediated by cholesterol synthesis supports B cell responses to vaccination.
    Nat Immunol. 2023 Jan 6. doi: 10.1038/s41590-022-01400.
    PubMed    


  27. HOUSTON S
    SARS-CoV-2 mucosal vaccine.
    Nat Immunol. 2023;24:1.
    PubMed    


    December 2022
  28. PALIN AC, Alter G, Crotty S, Ellebedy AH, et al
    Author Correction: The persistence of memory: defining, engineering, and measuring vaccine durability.
    Nat Immunol. 2022 Dec 26. doi: 10.1038/s41590-022-01414.
    PubMed    


  29. JEYANATHAN M, Vaseghi-Shanjani M, Afkhami S, Grondin JA, et al
    Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut-lung axis.
    Nat Immunol. 2022 Dec 1. doi: 10.1038/s41590-022-01354.
    PubMed     Abstract available


  30. PALIN AC, Alter G, Crotty S, Ellebedy AH, et al
    The persistence of memory: defining, engineering, and measuring vaccine durability.
    Nat Immunol. 2022 Dec 1. doi: 10.1038/s41590-022-01359.
    PubMed    


    November 2022
  31. PEDROZA-PACHECO I, McMichael AJ
    Immune signature atlas of vaccines: learning from the good responders.
    Nat Immunol. 2022 Nov 28. doi: 10.1038/s41590-022-01361.
    PubMed    


    October 2022
  32. FOURATI S, Tomalin LE, Mule MP, Chawla DG, et al
    Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination.
    Nat Immunol. 2022 Oct 31. pii: 10.1038/s41590-022-01329.
    PubMed     Abstract available


  33. HAGAN T, Gerritsen B, Tomalin LE, Fourati S, et al
    Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses.
    Nat Immunol. 2022 Oct 31. pii: 10.1038/s41590-022-01328.
    PubMed     Abstract available


  34. QUAST I, Tarlinton D
    Time is of the essence for vaccine success.
    Nat Immunol. 2022 Oct 21. pii: 10.1038/s41590-022-01347.
    PubMed    


    September 2022
  35. BRASU N, Elia I, Russo V, Montacchiesi G, et al
    Memory CD8(+) T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination.
    Nat Immunol. 2022 Sep 22. pii: 10.1038/s41590-022-01313.
    PubMed     Abstract available


    July 2022
  36. HERATI RS, Knorr DA, Vella LA, Silva LV, et al
    PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine.
    Nat Immunol. 2022 Jul 28. pii: 10.1038/s41590-022-01274.
    PubMed     Abstract available


  37. KEDZIERSKA K, Nguyen THO
    PD-1 blockade unblocks immune responses to vaccination.
    Nat Immunol. 2022 Jul 28. pii: 10.1038/s41590-022-01254.
    PubMed    


  38. YU D, Walker LSK, Liu Z, Linterman MA, et al
    Targeting TFH cells in human diseases and vaccination: rationale and practice.
    Nat Immunol. 2022 Jul 11. pii: 10.1038/s41590-022-01253.
    PubMed     Abstract available


  39. QI H, Liu B, Wang X, Zhang L, et al
    The humoral response and antibodies against SARS-CoV-2 infection.
    Nat Immunol. 2022;23:1008-1020.
    PubMed     Abstract available


    May 2022
  40. LUSTIG Y, Gonen T, Meltzer L, Gilboa M, et al
    Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
    Nat Immunol. 2022 May 9. pii: 10.1038/s41590-022-01212.
    PubMed     Abstract available


    March 2022

  41. IL-1-mediated inflammation induced by different RNA vaccines is context-specific.
    Nat Immunol. 2022 Mar 30. pii: 10.1038/s41590-022-01177.
    PubMed    


  42. KOBIYAMA K, Ishii KJ
    Making innate sense of mRNA vaccine adjuvanticity.
    Nat Immunol. 2022 Mar 30. pii: 10.1038/s41590-022-01168.
    PubMed    


  43. TAHTINEN S, Tong AJ, Himmels P, Oh J, et al
    IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines.
    Nat Immunol. 2022 Mar 24. pii: 10.1038/s41590-022-01160.
    PubMed     Abstract available


  44. LI C, Lee A, Grigoryan L, Arunachalam PS, et al
    Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine.
    Nat Immunol. 2022 Mar 14. pii: 10.1038/s41590-022-01163.
    PubMed     Abstract available


  45. MARTINEZ DR, Ooi EE
    A potential silver lining of delaying the second dose.
    Nat Immunol. 2022;23:349-351.
    PubMed    


    February 2022
  46. TOMALKA JA, Suthar MS, Deeks SG, Sekaly RP, et al
    Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.
    Nat Immunol. 2022 Feb 24. pii: 10.1038/s41590-022-01130.
    PubMed     Abstract available


  47. HALL VG, Ferreira VH, Wood H, Ierullo M, et al
    Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses.
    Nat Immunol. 2022 Feb 3. pii: 10.1038/s41590-021-01126.
    PubMed     Abstract available


    January 2022
  48. EGWANG TG, Owalla TJ, Kemigisha M
    COVID-19 vaccine trials must include helminth-infected cohorts.
    Nat Immunol. 2022 Jan 24. pii: 10.1038/s41590-021-01116.
    PubMed    


  49. DOWELL AC, Butler MS, Jinks E, Tut G, et al
    Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
    Nat Immunol. 2022;23:40-49.
    PubMed     Abstract available


    December 2021
  50. BERNARD NJ
    Vaccine thrombosis.
    Nat Immunol. 2021 Dec 22. pii: 10.1038/s41590-021-01111.
    PubMed    


    November 2021
  51. BREWER RC, Ramadoss NS, Lahey LJ, Jahanbani S, et al
    BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2.
    Nat Immunol. 2021 Nov 30. pii: 10.1038/s41590-021-01088.
    PubMed     Abstract available


  52. IRVINE EB, O'Neil A, Darrah PA, Shin S, et al
    Robust IgM responses following intravenous vaccination with Bacille Calmette-Guerin associate with prevention of Mycobacterium tuberculosis infection in macaques.
    Nat Immunol. 2021 Nov 22. pii: 10.1038/s41590-021-01066.
    PubMed     Abstract available



  53. NIAID workshop on secondary vaccine effects.
    Nat Immunol. 2021;22:1363-1366.
    PubMed    


    October 2021
  54. CORBETT KS, Werner AP, Connell SO, Gagne M, et al
    mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.
    Nat Immunol. 2021;22:1306-1315.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.